PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1279789
PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1279789
Global Medical Cannabis Market is valued approximately USD 8432.25 million in 2021 and is anticipated to grow with a healthy growth rate of more than 23.60% over the forecast period 2022-2029. Medical cannabis refers to the use of cannabis or cannabinoids to treat medical conditions or alleviate symptoms. These products may include dried cannabis flower, cannabis oil, capsules, and tinctures, among others. The global medical cannabis market is growing rapidly due to increasing awareness of the potential health benefits of cannabis-based products, the legalization of medical cannabis in several countries, and the growing acceptance of cannabis for medical use. Moreover, increasing demand for natural and alternative therapies and growing investment and research is creating lucrative growth opportunity for the market over the forecast period 2022-2029.
In December 2020, the United Nations Commission on Narcotic Drugs voted to remove cannabis from Schedule IV of the 1961 Single Convention on Narcotic Drugs, recognizing its potential medical benefits and paving the way for more countries to legalize medical cannabis. In 2020, the European Union (EU) amended its regulations to allow for the use of cannabis-based medicines for the treatment of chronic pain, spasticity, and nausea associated with chemotherapy. In February 2021, the government of United Kingdom announced that it would allow medical cannabis to be prescribed by specialist doctors for patients with chronic pain, epilepsy, and other conditions. However, the high cost of Medical Cannabis stifles market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Medical Cannabis Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is currently the largest market for medical cannabis, with the United States and Canada accounting for a significant share of the market. In the United States, more than 35 states have legalized medical cannabis, creating a large market for cannabis-based products. The increasing prevalence of chronic diseases and the growing demand for natural and alternative therapies are also driving market growth in this region. The Asia-Pacific region is expected to witness significant growth in the medical cannabis market due to the increasing acceptance of medical cannabis, growing patient awareness, and the presence of a large patient population with chronic diseases. Countries such as Australia, New Zealand, and Thailand have legalized medical cannabis, while others such as India and China are considering legalization.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Product Type offerings of key players. The detailed segments and sub-segment of the market are explained below.
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
List of figures
List of tables and figures and dummy in nature, final lists may vary in the final deliverable